Investis Digital Announces Strategic Partnership with Clinpal
We are pleased to announce that we have entered into a strategic partnership with eClinicalHealth (ClinpalTM). This alliance combines Investis Digital’s propriety framework, Connected Content™, known for attracting, targeting, and engaging hard-to-reach patient populations, and Clinpal’s cloud-based platform, which connects those patients, study teams, and sites during a clinical trial.
This partnership addresses two critical unmet needs – operational inefficiency and lack of transparency in the recruitment process for study teams conducting clinical studies. The integrated approach has proven to provide study teams faster, patient-centric, and cost-effective recruitment.
Ian Koenig, SVP, Global Head of Life Sciences at Investis Digital comments, “we’ve taken apart everything that has to do with the patient recruitment flow model and rebuilt it more efficiently. Our clients no longer have to wonder why their enrollment curve looks the way it does. Through our platform and coordinated effort, they can dive deep into the data at a country, region, and site-level in real-time, and make data-driven actions on their recruitment efforts.”
Key benefits of the integrated solution include:
- Advanced subject profiling
- Omni-channel engagement tactics
- Sophisticated pre-screening
- Candidate flow-through management
- Real-time analytics
- Clinical operations support
The Investis Digital-Clinpal solution provides comprehensive stakeholder mapping, digital and non-digital content creation, analytics, and reporting, alongside a vast array of tools, including e-consent and EDC, to fulfill any patient recruitment need study teams may have. Its continuous feedback loop allows study teams to react quickly and adjust accordingly to ensure optimal operational efficiency. This solution also asserts HIPAA and GDPR compliance.
“Patient engagement and managing the warm handover to study sites is at the heart of clinical trials. With Investis Digital’s powerful performance marketing solutions coupled with our scalable platform that allows you to run highly complex studies from rare and orphan diseases to global mega-trials will potentially revolutionize the future of patient recruitment”, said Karl Landert, CEO of eClinicalHealth.
Interested in Learning More? Contact Us Today